Community hospital versus tertiary hospital comparison in the treatment and outcome of patients with acute coronary syndrome: A New Zealand experience

New Zealand Medical Journal

Volumn 119, Issue 1238, 2006, Pages

  Tang, Eng Wei ^a,b   Wong, Cheuk Kit ^a   Herbison, Peter ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b PALMERSTON NORTH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMMUNITY HOSPITAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY CARE UNIT; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; FEMALE; HAZARD ASSESSMENT; HEALTH CARE FACILITY; HEART ARREST; HEART CATHETERIZATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART RATE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT TRANSPORT; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE;

EID: 84858941874     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Non ST-elevation myocardial infarction: New Zealand management guidelines. Non ST-Elevation Myocardial Infarction Guidelines Group and the New Zealand Branch of The Cardiac Society of Australia and New Zealand. N Z Med J. 2005;118(1223). URL: http://www.nzma.org.nz/journal/ 118-1223/1680/
2. ST-elevation myocardial infarction: New Zealand management guidelines. ST-Elevation Myocardial Infarction Guidelines Group and the New Zealand Branch of the Cardiac Society of Australia and New Zealand. N Z Med J. 2005;118(1223). URL: http://www.nzma.org.nz/journal/118-1223/1679/
3. Ellis C, Gamble G, French J, et al. Management of patients admitted with an acute coronary syndrome in New Zealand: results of a comprehensive nationwide audit. N Z Med J. 2004;117(1197). URL: http://www.nzma.org.nz/ journal/117-1197/953
4. Ellis C, Devlin G, French J, et al. Acute coronary syndrome patients in New Zealand receives less invasive management when admitted to hospitals without invasive facilities. N Z Med J. 2004;117(1197). URL: http://www.nzma.org.nz/journal/117-1197/954
5. Tang EW, Wong CK, Wilkins GT, et al. Use of evidence-based medicine for acute coronary syndrome. N Z Med J. 2005;118(1223). URL: http://www.nzma.org.nz/journal/118-1223/1678/
6. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001;22:554-72.
7. Fox KA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2002;23:1177-89.
8. Calvin JE, Roe MT, Chen A, et al. Higher mortality and less evidence-based therapies among Medicaid-insured patients with high-risk acute coronary syndrome: Results from CRUSADE. Abstract. J Am Coll Cardiol. 2004;43(Suppl 2):A413.
9. Van De Werf F, Gore JM, Avezum A, et al, for the GRACE investigators. Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. BMJ. 2005;330:441.
10. Mehta SR, Cannon CP, Fox KA, et al. Routine vs. selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005;293:2908-17.
11. de Winter RJ, Windhausen F, Cornel JH, et al, for the Invasive versus Conservative Treatment in Unstable Coronary Syndrome (ICTUS) Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med. 2005;353:1095-104.
12. Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003;290:1593-9.
13. Ryan JW, Peterson ED, Chen AY, et al. Optimal Timing of Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes. Insights From the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry. Circulation. 2005;112:3049-57.
14. Stukel TA, Lucas FL, Wennburg DE, et al. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare patients with acute myocardial infarction. JAMA. 2005;293:1329-37.
15. Bhatt DL, Roe MT, Peterson ED, et al, for the CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004;292:2096-104.
16. Tricoci P, Mulgund J, Harrington RA, et al. Trends for utilisation of early cardiac catheterisation for non-ST-segment elevation acute coronary syndromes by patient risk status in the CRUSADE quality improvement initiative. Abstract. Circulation. 2005;112(17):Suppl II-743, Article 3469.
17. Cohen MG, Hill C, Filby SJ, et al. Underutilization of cardiac catheterization in high-risk patients with acute coronary syndrome is associated with increased mortality: lessons from the CRUSADE registry. Abstract. Circulation. 2005;112(7):Suppl II-744, Article 3471.